Description: Pharmaxi is a CRO which implements phase III - IV Clinical Trials as well as postmarketing studies and registries using proprietary EDC system OnlineCRF
medical devices (590) cro (472) clinical trials (425) dietary supplements (289) non-interventional studies (8)
Pharmaxi is a mid-sized CRO, operating in Ukraine, Poland, and other European countries. These countries are attractive locations for clinical trials. Pharmaxi positions itself as an effective, client-oriented, flexible, innovative and cost-attractive company.
The main focus of Pharmaxi is the conduction of phase II-IV clinical trials and late-phase large-scale non-interventional studies. Services embrace all types of activities, from study design negotiation to the final study report creation. If some specific tasks are not covered by in-house facilities, (e.g. drug depot, logistics, insurance), we subcontract them to trusted and fully-vetted local vendors.
In rare cases, we develop unique services (including SOPs and working instructions) on demand. So, feel free to contact us to make sure that your clinical trial services are not only well coordinated and conform to international standards, but also exceed your quality and budget expectations.